Table 4 Antagonistic biomarkers expression: Correlation among biomarkers expression and clinico-histopathological features.

From: Ki-67, p53 and BCL-2 Expressions and their Association with Clinical Histopathology of Breast Cancer among Women in Tanzania

  

1

2

3

4

5

6

7

8

1.

Age

        

2.

Cancer stage

0.043

       

3.

Cancer grade

−0.048

0.475**

      

4.

Nodule status

0.002

0.418**

0.271*

     

5.

Ki-67 biomarker

0.160

−0.064

−0.268*

0.035

    

6.

p53 biomarker

−0.134

−0.281*

−0.109

−0.131

0.103

   

7.

BCL-2 biomarker

0.004

0.002

−0.024

0.048

0.331**

−0.238*

  

8.

Tumor size

0.077

0.612**

0.337**

0.115

−0.217

−0.371**

−0.103

 
  1. **p-value < 0.01.
  2. *p-value < 0.05.
Back to article page